Biochimie. 2005 Jan;87(1):9-13.

PPAR gamma, 10 years later.

Source

Division of Endocrinology, Diabetes, and Metabolism, Department of Medicine, and The Penn Diabetes Center, University of Pennsylvania School of Medicine, Philadelphia, PA 19104-6149, USA. lazar@mail.med.upenn.edu

Abstract

It is now over 10 years since the discovery of peroxisome proliferator activated receptor gamma (PPAR gamma) and its unique role in adipogenesis. The subsequent identification of PPAR gamma as the target of insulin sensitizing drugs certified this ligand-regulated transcription factor as an exciting link between adipocyte biology and peripheral insulin resistance. Here, I summarize the great progress that has been made over the past decade in elucidating the biology of PPAR gamma and its role in adipogenesis and glucose metabolism. Prospects for future research leading to new therapies for obesity and diabetes are also discussed.

PMID:: 15733730; [PubMed - indexed for MEDLINE]

Publication Types, MeSH Terms, Substances

Publication Types

Review

MeSH Terms

Substances

LinkOut - more resources

Full Text Sources

Other Literature Sources

Supplemental Content

Save items

Related citations in PubMed

Gene expression profile of adipocyte differentiation and its regulation by peroxisome proliferator-activated receptor-gamma agonists. [Endocrinology. 2002]
Gene expression profile of adipocyte differentiation and its regulation by peroxisome proliferator-activated receptor-gamma agonists.
Gerhold DL, Liu F, Jiang G, Li Z, Xu J, Lu M, Sachs JR, Bagchi A, Fridman A, Holder DJ, et al. Endocrinology. 2002 Jun; 143(6):2106-18.
Novel genes regulated by the insulin sensitizer rosiglitazone during adipocyte differentiation. [Diabetes. 2002]
Novel genes regulated by the insulin sensitizer rosiglitazone during adipocyte differentiation.
Albrektsen T, Frederiksen KS, Holmes WE, Boel E, Taylor K, Fleckner J. Diabetes. 2002 Apr; 51(4):1042-51.
Impact of increased PPARgamma activity in adipocytes in vivo on adiposity, insulin sensitivity and the effects of rosiglitazone treatment. [Endocr J. 2008]
Impact of increased PPARgamma activity in adipocytes in vivo on adiposity, insulin sensitivity and the effects of rosiglitazone treatment.
Takasawa K, Kubota N, Terauchi Y, Kadowaki T. Endocr J. 2008 Aug; 55(4):767-76. Epub 2008 May 28.
Review Review: peroxisome proliferator-activated receptor-gamma and its role in the development and treatment of diabetes. [Exp Diabesity Res. 2004]
Review Review: peroxisome proliferator-activated receptor-gamma and its role in the development and treatment of diabetes.
Leff T, Mathews ST, Camp HS. Exp Diabesity Res. 2004 Apr-Jun; 5(2):99-109.
Review Role of PPARg2 transcription factor in thiazolidinedione-induced insulin sensitization. [J Pharm Pharmacol. 2012]
Review Role of PPARg2 transcription factor in thiazolidinedione-induced insulin sensitization.
Saraf N, Sharma PK, Mondal SC, Garg VK, Singh AK. J Pharm Pharmacol. 2012 Feb; 64(2):161-71. Epub 2011 Oct 13.

See reviews... See all...

Cited by 28 PubMed Central articles

The mTOR Signalling Pathway in Human Cancer. [Int J Mol Sci. 2012]
The mTOR Signalling Pathway in Human Cancer.
Pópulo H, Lopes JM, Soares P. Int J Mol Sci. 2012; 13(2):1886-918. Epub 2012 Feb 10.
Anticancer Role of PPARgamma Agonists in Hematological Malignancies Found in the Vasculature, Marrow, and Eyes. [PPAR Res. 2010]
Anticancer Role of PPARgamma Agonists in Hematological Malignancies Found in the Vasculature, Marrow, and Eyes.
Simpson-Haidaris PJ, Pollock SJ, Ramon S, Guo N, Woeller CF, Feldon SE, Phipps RP. PPAR Res. 2010; 2010:814609. Epub 2010 Feb 28.
Downregulated expression of the secreted glycoprotein follistatin-like 1 (Fstl1) is a robust hallmark of preadipocyte to adipocyte conversion. [Mech Dev. 2010]
Downregulated expression of the secreted glycoprotein follistatin-like 1 (Fstl1) is a robust hallmark of preadipocyte to adipocyte conversion.
Wu Y, Zhou S, Smas CM. Mech Dev. 2010 Apr; 127(3-4):183-202. Epub 2010 Jan 4.

See all...

Related information

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
Substance (MeSH Keyword)
PubChem chemical substance (submitted) records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Cited in PMC
Full-text articles in the PubMed Central Database that cite the current articles.

Recent activity

Clear Turn Off Turn On

PPAR gamma, 10 years later.
PPAR gamma, 10 years later.
Biochimie. 2005 Jan ;87(1):9-13.

PubMed
Pre-eclampsia.
Pre-eclampsia.
Lancet. 2005 Feb 26-Mar 4 ;365(9461):785-99.

PubMed
Fixed-interval performance and self-control in children.
Fixed-interval performance and self-control in children.
J Exp Anal Behav. 1992 Mar ;57(2):187-99.

PubMed
Randomised controlled trial of anti-smoking advice: final (20 year) results.
Randomised controlled trial of anti-smoking advice: final (20 year) results.
J Epidemiol Community Health. 1992 Feb ;46(1):75-7.

PubMed
Do men and women differ in their response to interdisciplinary chronic pain mana...
Do men and women differ in their response to interdisciplinary chronic pain management?
Pain. 2005 Mar ;114(1-2):37-46. Epub 2005 Jan 22 .

PubMed

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

PubMed

Result Filters

Display Settings:

Send to: